Candida auris Infection in COVID-19 Patients

摘要

Patients with COVID-19 hospitalized in intensive care in India developed multidrug-resistant C. auris candidemia associated with a 60% mortality rate. The COVID-19 pandemic is emerging or reemerging in many countries worldwide and in nearly all U.S. states. Intensive care units (ICUs) are at capacity, and trained ICU staff are in short supply. The most susceptible patients are older and have comor-bid conditions, and secondary infections in this population have been reported increasingly.